Showing 171 - 180 of 1,665
Persistent link: https://www.econbiz.de/10005750544
Persistent link: https://www.econbiz.de/10005750612
The G8 is considering committing to purchase vaccines against diseases concentrated in low-income countries (if and when desirable vaccines are developed) as a way to spur research and development on vaccines for these diseases. Under such an 'advance market commitment,' one or more sponsors...
Persistent link: https://www.econbiz.de/10005792820
In this survey chapter on pricing and reimbursement in U.S. pharmaceutical markets, we first provide background information on important federal legislation, institutional details regarding distribution channel logistics, definitions of alternative price measures, related historical...
Persistent link: https://www.econbiz.de/10008531891
We assess size and scope-related economies in the global advertising and marketing services business. A translog cost function is employed wherein a firm’s costs vary according to its scale and two dimensions of the scope of its operations. One dimension of firm scope relates to how its...
Persistent link: https://www.econbiz.de/10008579407
Persistent link: https://www.econbiz.de/10008580749
Persistent link: https://www.econbiz.de/10008580788
Persistent link: https://www.econbiz.de/10008580961
Persistent link: https://www.econbiz.de/10008581159
In this paper we focus on a mystery we uncovered while undertaking a detailed audit of the US Bureau of Labor Statistics producer price index (PPl). We summarize our puzzle as follows. From January 1984 through December 1989.the BLS price Index for SIC 28341 (prescription pharmaceutical...
Persistent link: https://www.econbiz.de/10005775204